Dental Caries and Other Aspects of Oral Health That Impact Patients With Hemophilia
Researchers sought to determine patterns of oral health in patients with hemophilia.
Researchers sought to determine patterns of oral health in patients with hemophilia.
Researchers sought to determine whether biases were present in clinical trials included in the package inserts of coagulation factors used for the treatment of hemophilia.
Researchers investigated the safety and feasibility of Project GYM, a personal trainer-led physical fitness program for young men with hemophilia.
Researchers are seeking to evaluate outcomes after initiation of emicizumab and concomitant BPAs in patients with hemophilia A and FVIII inhibitors.
Researchers sought to determine whether emicizumab would be safe and effective in pediatric patients with hemophilia A with FVIII inhibitors.
Researchers sought to determine whether rVIII-SingleChain therapy would be safe and effective as a long-term prophylaxis option for previously treated patients with hemophilia A.
Researchers sought to revise the GOAL-Hēm patient-reported outcomes tool to be more patient-centric for patients with hemophilia.
Researchers sought to determine whether efanesoctocog alfa may yield high sustained FVIII activity and improve bleed protection in patients with severe hemophilia A.
In open-label study, substantial increase seen in factor VIII activity at weeks 49 to 52 of follow-up.
In preclinical studies, ASC618 has been shown to have at least a 10-fold increase in the biosynthesis and secretion of FVIII compared with native human FVIII bioengineered constructs.